Inflammation and dry eye disease—where are we?
Author:
Corresponding Author:

Srinivas K Rao. Darshan Eye Care & Surgical Centre, Chennai, Tamil Nadu 600040, India. srinikrao@gmail.com

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The presence of inflammation in dry eye disease (DED) results in increased patient symptomatology, ocular surface damage and worsening tear dysfunction. It also affects the health of meibomian glands and their secretions which further aggravates ocular surface disease. This article reviews current knowledge regarding ocular surface inflammation in DED and explores the relationships between the vicious cycles of DED, inflammation and meibomian gland dysfunction (MGD). The clinical evaluation of eyes with such changes, markers that identify the presence of inflammation on the ocular surface and current treatment options are discussed.

    Reference
    Related
    Cited by
Get Citation

Srinivas K Rao, Rishi Mohan, Nikhil Gokhale, et al. Inflammation and dry eye disease—where are we?. Int J Ophthalmol, 2022,15(5):820-827

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:January 25,2021
  • Revised:October 25,2021
  • Adopted:
  • Online: April 27,2022
  • Published: